TORRENT PHARMACEUTICALS L vs Vivo Bio Tech Ltd

A side-by-side comparison of TORRENT PHARMACEUTICALS L (TORNTPHARM) and Vivo Bio Tech Ltd (VIVOBIOTECHLTD) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

TORNTPHARM logo
TORRENT PHARMACEUTICALS L
TORNTPHARM
₹4,961-0.09%
Leads on the numbers
VS
VIVOBIOTECHLTD logo
Vivo Bio Tech Ltd
VIVOBIOTECHLTD
₹0+0.00%
The verdict

On the numbers, TORRENT PHARMACEUTICALS L leads TORNTPHARM vs VIVOBIOTECHLTD on 9 of 14 metrics (1 undecided). See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation22
  • Profitability31
  • Growth10
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

77.61
P/E ratio
-15.60
18.67
P/B ratio
0.49
0.76%
Dividend yield
0.00%
₹63.92
EPS
₹-0.77

Profitability

TORNTPHARM takes 3/4

How efficiently each company turns capital and sales into profit. Higher is better.

27.40%
Return on equity
-2.00%
15.00%
Return on capital
7.29%
33.00%
EBITDA margin
39.10%
15.29%
Net margin
-3.21%

Growth

TORNTPHARM takes 1/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

13.27%
Revenue CAGR (3Y)
0.70%
19.75%
Profit CAGR (3Y) even
—

Size & financial health

TORNTPHARM takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.68L Cr
Market cap
₹45 Cr
₹13,980 Cr
Revenue
₹53 Cr
₹2,138 Cr
Net profit
₹-2 Cr
1.69
Debt / equity
0.72
TORRENT PHARMACEUTICALS L
  • + ["Company is expected to give good quarter", "Company has a good return on equity (ROE) track record: 3 Years ROE 26.2%", "Company has been maintaining a healthy dividend payout of 57.8%"]
  • − ["Stock is trading at 20.4 times its book value", "Promoter holding has decreased over last quarter: -7.53%", "The company has delivered a poor sales growth of 11.8% over past five years.", "Company might be capitalizing the interest cost"]
Vivo Bio Tech Ltd
  • + ["Stock is trading at 0.48 times its book value"]
  • − ["Company has low interest coverage ratio.", "Promoter holding has decreased over last quarter: -4.81%", "The company has delivered a poor sales growth of 0.59% over past five years.", "Promoter holding is low: 30.6%", "Company has a low return on equity of 2.24% over last 3 years."]
TORRENT PHARMACEUTICALS L full analysis Vivo Bio Tech Ltd full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.